Recombinant Human RAB3D Protein, N-His

Description of Recombinant Human RAB3D Protein, N-His

Introduction

Recombinant proteins are proteins that are produced through genetic engineering techniques, allowing for the production of large quantities of specific proteins. These proteins have a wide range of applications in various fields, including medicine, biotechnology, and research. One such protein is the Recombinant Human RAB3D Protein, which has gained significant attention due to its unique structure, activity, and potential applications.

Structure of Recombinant Human RAB3D Protein

The Recombinant Human RAB3D Protein is a member of the RAB family of small GTPases, which are involved in regulating intracellular vesicle trafficking and fusion. It is composed of 219 amino acids and has a molecular weight of approximately 24 kDa. The protein has a highly conserved GTP-binding domain, which is essential for its activity, and a C-terminal hypervariable region that allows for specific interactions with other molecules.

Activity of Recombinant Human RAB3D Protein

The main function of Recombinant Human RAB3D Protein is to regulate the exocytosis of secretory vesicles, particularly in the pancreas and the brain. It does this by interacting with other proteins, such as RIM and RIM-BP, which are involved in the release of neurotransmitters and hormones. Additionally, this protein has been shown to play a role in the regulation of insulin secretion in pancreatic beta cells, making it a potential target for diabetes treatment.

Application of Recombinant Human RAB3D Protein

The unique structure and activity of Recombinant Human RAB3D Protein make it a valuable tool in various applications. One of its primary uses is in the study of vesicle trafficking and exocytosis. By overexpressing or silencing this protein in cells, researchers can better understand its role in these processes and its interactions with other proteins. This can lead to a better understanding of diseases that involve abnormalities in vesicle trafficking, such as diabetes and neurodegenerative disorders.

Furthermore, Recombinant Human RAB3D Protein has potential therapeutic applications. As mentioned earlier, it has been shown to play a role in insulin secretion, making it a potential target for diabetes treatment. Additionally, studies have shown that this protein is overexpressed in several types of cancer, including breast, lung, and colon cancer. This suggests that it may have a role in cancer development and progression, making it a potential target for cancer therapy.

Moreover, Recombinant Human RAB3D Protein has been used in the development of diagnostic tools for various diseases. For example, it has been used as an antigen in ELISA assays to detect antibodies against this protein in patients with autoimmune diseases, such as type 1 diabetes and multiple sclerosis. This can aid in the early diagnosis and treatment of these diseases.

Conclusion

In summary, Recombinant Human RAB3D Protein is a small GTPase that plays a crucial role in regulating vesicle trafficking and exocytosis. Its unique structure and activity make it a valuable tool in various fields, including research, medicine, and biotechnology. With its potential applications in diabetes treatment, cancer therapy, and disease diagnosis, this protein continues to be a subject of interest for scientists and researchers.